 SAN DIEGO and CALGARY, AB, April 29, 2021 PRNewswire -- Oncolytics Biotech Inc. NASDAQ: ONCY TSX: ONC today announced the acceptance of an abstract discussing its pancreatic adenocarcinoma trial at the 2021 American Society of Clinical Oncology ASCO Annual Meeting, which is taking place virtually from June 4 8, 2021. Details on the abstract and a corresponding poster presentation are shown below. 